Starcoin Group Limited Signs Research and Strategic Advisory Agreement with Johns Hopkins Scaling Lab
I'm PortAI, I can summarize articles.
Starcoin Group Limited has signed a five-year Sponsored Research and Strategic Advisory Agreement with Johns Hopkins Scaling Lab. The collaboration aims to advance technologies in oral insulin and drug-delivery systems, enhancing Starcoin's competitiveness in the global diabetes therapeutics market. The agreement will support sustained research and knowledge transfer. This news was published by Starcoin Group via the Hong Kong Stock Exchange on December 18, 2025.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments